Journal
EXPERT REVIEW OF MEDICAL DEVICES
Volume 5, Issue 1, Pages 33-39Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/17434440.5.1.33
Keywords
baroreceptors; carotid sinus; drug resistant; hypertension; surgery
Categories
Ask authors/readers for more resources
Resistant hypertension has a high prevalence and is associated with high morbidity and mortality. The Rheos (R) Baroreflex Hypertension Therapy (TM) System is an implantable device that offers a completely new approach to treating patients with resistant hypertension by electrically activating the carotid baroreflex. Preliminary results from current feasibility clinical trials have shown sustained decreases in blood pressure after 1 year. The pivotal trial for US FDA approval and market release is currently ongoing. This article profiles the Rheos System and evaluates the treatment of resistant hypertension in general.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available